Depreciation, Depletion and Amortization of Vivos Therapeutics, Inc. from 31 Mar 2021 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Summary
Vivos Therapeutics, Inc. quarterly and annual Depreciation, Depletion and Amortization in USD history and change rate from 31 Mar 2021 to 31 Mar 2025.
  • Vivos Therapeutics, Inc. Depreciation, Depletion and Amortization for the quarter ending 31 Mar 2025 was $177,000, a 21% increase year-over-year.
  • Vivos Therapeutics, Inc. annual Depreciation, Depletion and Amortization for 2024 was $581,000, a 6.4% decline from 2023.
  • Vivos Therapeutics, Inc. annual Depreciation, Depletion and Amortization for 2023 was $621,000, a 7.2% decline from 2022.
  • Vivos Therapeutics, Inc. annual Depreciation, Depletion and Amortization for 2022 was $669,000, a 8.7% decline from 2021.
Source SEC data
View on sec.gov
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Change (%)
Depreciation, Depletion and Amortization, Annual (USD)
Depreciation, Depletion and Amortization, YoY Annual Change (%)

Vivos Therapeutics, Inc. Quarterly Depreciation, Depletion and Amortization (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $177,000 +$31,000 +21% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q1 2024 $146,000 -$29,000 -17% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025 2025 Q1
Q1 2023 $175,000 +$134,000 +327% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024 2024 Q1
Q1 2022 $41,000 -$136,000 -77% 01 Jan 2022 31 Mar 2022 10-Q 08 Jun 2023 2023 Q1
Q1 2021 $177,000 01 Jan 2021 31 Mar 2021 10-Q/A 25 Nov 2022 2022 Q1

Vivos Therapeutics, Inc. Annual Depreciation, Depletion and Amortization (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $581,000 -$40,000 -6.4% 01 Jan 2024 31 Dec 2024 10-K 31 Mar 2025 2024 FY
2023 $621,000 -$48,000 -7.2% 01 Jan 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
2022 $669,000 -$64,000 -8.7% 01 Jan 2022 31 Dec 2022 10-K/A 30 Jul 2024 2023 FY
2021 $733,000 01 Jan 2021 31 Dec 2021 10-K 30 Mar 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.